HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexey A Belogurov Selected Research

Infections

10/2021Protein PGLYRP1/Tag7 Peptides Decrease the Proinflammatory Response in Human Blood Cells and Mouse Model of Diffuse Alveolar Damage of Lung through Blockage of the TREM-1 and TNFR1 Receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alexey A Belogurov Research Topics

Disease

9Multiple Sclerosis
01/2023 - 01/2006
5Neoplasms (Cancer)
11/2022 - 01/2012
3COVID-19
05/2024 - 10/2021
3Autoimmune Diseases (Autoimmune Disease)
01/2020 - 01/2008
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2013 - 01/2006
2Cytokine Release Syndrome
09/2022 - 10/2021
2Acute Lung Injury
01/2022 - 10/2021
2Inflammation (Inflammations)
10/2021 - 01/2016
2Disease Progression
01/2008 - 02/2006
1Dementia (Dementias)
02/2024
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2024
1Ductal Carcinoma
11/2022
1Cicatrix (Scar)
09/2022
1Gliosis
09/2022
1Cysts
09/2022
1Hyperventilation
01/2022
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Infections
10/2021
1Pathologic Processes
01/2020
1Lymphoma (Lymphomas)
11/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2016
1Virus Diseases (Viral Diseases)
01/2016
1Encephalitis (Encephalitis, Rasmussen)
01/2013
1Epstein-Barr Virus Infections
12/2011

Drug/Important Bio-Agent (IBA)

9Myelin Basic ProteinIBA
01/2023 - 01/2006
4Peptides (Polypeptides)IBA
01/2023 - 01/2008
4AutoantigensIBA
01/2023 - 01/2008
4CytokinesIBA
09/2022 - 01/2016
4AutoantibodiesIBA
01/2020 - 02/2006
3Proteins (Proteins, Gene)FDA Link
05/2024 - 10/2021
3AntigensIBA
11/2022 - 12/2011
2Proteasome Endopeptidase Complex (Proteasome)IBA
09/2021 - 11/2020
2AntibodiesIBA
12/2011 - 01/2006
1Vesicle-Associated Membrane Protein 3IBA
05/2024
1Membrane Proteins (Integral Membrane Proteins)IBA
02/2024
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2024
1TAK 779IBA
01/2024
1tocilizumab (atlizumab)FDA Link
01/2024
1AntitoxinsIBA
11/2022
1Bacterial ToxinsIBA
11/2022
1Bacillus amyloliquefaciens barstar protein (barstar)IBA
11/2022
1Bacillus amyloliquefaciens ribonucleaseIBA
11/2022
1Designed Ankyrin Repeat ProteinsIBA
11/2022
1ChemokinesIBA
09/2022
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2022
1LipopolysaccharidesIBA
01/2022
1Irinotecan (Camptosar)FDA LinkGeneric
01/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022
1olaparibIBA
01/2022
1Type I Tumor Necrosis Factor ReceptorsIBA
10/2021
1Immune Checkpoint InhibitorsIBA
09/2021
1SpermineIBA
11/2020
1CarbonatesIBA
11/2020
1BuffersIBA
11/2020
1Phosphates (Orthophosphate)IBA
11/2020
1PolyaminesIBA
11/2020
1Immunoglobulin G (IgG)IBA
01/2020
1LigandsIBA
11/2018
1Small Interfering RNA (siRNA)IBA
06/2016
1ProteomeIBA
01/2016
1Immunoglobulins (Immunoglobulin)IBA
12/2014
1Liposomes (Liposome)IBA
01/2013
1Unilamellar LiposomesIBA
01/2013
1Conditioned Culture MediaIBA
01/2012
1Monoclonal AntibodiesIBA
01/2011
1EpitopesIBA
01/2008
1Biomarkers (Surrogate Marker)IBA
01/2008

Therapy/Procedure

6Therapeutics
11/2022 - 01/2011
1Immunotherapy
09/2021